NCT02693821View on ClinicalTrials.gov

Persistent Postoperative Pain Incidence With Gabapentin Used

PHASE4CompletedINTERVENTIONAL
Enrollment

122

Participants

Timeline

Start Date

December 31, 2015

Primary Completion Date

January 31, 2016

Study Completion Date

June 30, 2022

Conditions
Pain, Postoperative
Interventions
DRUG

Gabapentin

gabapentin 300 mg per day, orally during 30 days

DRUG

Placebo

Placebo 300 mg per day, orally during 30 days

Trial Locations (1)

C1199ABB

Sofía Konekny, Almagro

All Listed Sponsors
lead

Hospital Italiano de Buenos Aires

OTHER

NCT02693821 - Persistent Postoperative Pain Incidence With Gabapentin Used | Biotech Hunter | Biotech Hunter